Related Experiment Video
Updated: Aug 1, 2025

Collection of Serum- and Feeder-free Mouse Embryonic Stem Cell-conditioned Medium for a Cell-free Approach
Published on: January 8, 2017
Recent clinical trials with stem cells to slow or reverse normal aging processes
1Pharmacology and Therapeutics, Craven, 91360 Villemoisson-sur-Orge, France.
Abstract:
Aging is associated with a decline in the regenerative potential of stem cells. In recent years, several clinical trials have been launched in order to evaluate the efficacy of mesenchymal stem cell interventions to slow or reverse normal aging processes (aging conditions). Information concerning those clinical trials was extracted from national and international databases (United States, EU, China, Japan, and World Health Organization). Mesenchymal stem cell preparations were in development for two main aging conditions: physical frailty and facial skin aging. With regard to physical frailty, positive results have been obtained in phase II studies with intravenous Lomecel-B (an allogeneic bone marrow stem cell preparation), and a phase I/II study with an allogeneic preparation of umbilical cord-derived stem cells was recently completed. With regard to facial skin aging, positive results have been obtained with an autologous preparation of adipose-derived stem cells. A further sixteen clinical trials for physical frailty and facial skin aging are currently underway. Reducing physical frailty with intravenous mesenchymal stem cell administration can increase healthy life expectancy and decrease costs to the public health system. However, intravenous administration runs the risk of entrapment of the stem cells in the lungs (and could raise safety concerns). In addition to aesthetic purposes, clinical research on facial skin aging allows direct evaluation of tissue regeneration using sophisticated and precise methods. Therefore, research on both conditions is complementary, which facilitates a global vision.
Insights
Mesenchymal stem cell therapies show promise for physical frailty and facial skin aging. Clinical trials are ongoing, with early results suggesting potential benefits for healthy life expectancy and tissue regeneration.
Area of Science:
- Gerontology and Regenerative Medicine
- Stem Cell Biology and Therapeutics
Background:
- Aging diminishes stem cell regenerative capacity, prompting research into stem cell interventions.
- Mesenchymal stem cell (MSC) therapies are being investigated to combat age-related conditions.
- Clinical trials are evaluating MSC efficacy for physical frailty and facial skin aging.
Purpose of the Study:
- To review current clinical trials on mesenchymal stem cell interventions for aging conditions.
- To assess the efficacy and safety of MSCs in treating physical frailty and facial skin aging.
- To understand the complementary nature of research in these two aging areas.
Main Methods:
- Systematic extraction of data from national and international clinical trial databases (US, EU, China, Japan, WHO).
- Analysis of ongoing and completed clinical trials for physical frailty and facial skin aging.
- Review of reported outcomes for specific MSC preparations (Lomecel-B, umbilical cord-derived MSCs, adipose-derived MSCs).
Main Results:
- Positive phase II results for intravenous Lomecel-B in physical frailty.
- Completion of a phase I/II study for umbilical cord-derived MSCs in physical frailty.
- Positive results for autologous adipose-derived stem cells in facial skin aging.
- Sixteen additional clinical trials are currently active for these conditions.
Conclusions:
- Mesenchymal stem cell interventions show potential for improving healthy life expectancy and public health outcomes in physical frailty.
- Research into facial skin aging using MSCs offers insights into tissue regeneration.
- Investigating both physical frailty and skin aging provides a comprehensive view of MSC therapeutic potential in aging.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Stem Cell Culture
iPS Cell Differentiation
Tissue Renewal without Stem Cells
However, failure of such a system...
Adult Stem Cells
The Effect of Aging on Tissues

